|
|
News Breaks | | | | September 10, 2012 | | 07:43 EDT |  | ELGX | Endologix shares should be bought on weakness, says Oppenheimer
Oppenheimer believes that an insider's sale of Endologix's stock, along with an upcoming intellectual property trial, have weighed on Endologix's shares. However, the firm doesn't view either of these events as important and maintains an Outperform rating on the shares. | |
|
News For ELGX From The Last 14 Days Check below for free stories on ELGX the last two weeks. |
|
|
| There are no results for ELGX |
|
|
|
|
|
|
